ERN1 and neoplasm: In addition to the direct effect of IRE1 inhibitors on the tumor cells, one might also consider their use in combination with current therapies, the most common of which comprising the combination of radio‐ and chemotherapy (the latter with the alkylating agent TMZ; Stupp et al, 2005).